Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment

Clin J Gastroenterol. 2023 Apr;16(2):206-215. doi: 10.1007/s12328-022-01733-2. Epub 2022 Nov 20.

Abstract

A woman in her late 70 s was diagnosed with liver injury at a health examination. Despite treatment with ursodeoxycholic acid at a nearby hospital, her transaminase levels elevated in two peaks. She was transferred to our hospital 77 days after the health examination. She weighed 42 kg and had a low body mass index of 19.8 kg/m2. Viral markers, including immunoglobulin A (IgA) against hepatitis E virus (anti-HEV IgA), were negative. Drug-induced liver injury was negligible. We suspected autoimmune hepatitis because of the patient's female gender and positive antinuclear antibody. However, prednisolone and azathioprine failed to completely improve her hepatitis. On day 643, anti-HEV IgA was re-evaluated and found to be positive. She was diagnosed with autochthonous chronic hepatitis E because the virus strains in the preserved serum on day 77 and the serum on day 643 had identical nucleotide sequences (genotype 3a). Following prednisolone and azathioprine discontinuation, ribavirin (RBV) was administered for 3 months. HEV RNA disappeared and remained negative for more than 6 months after the cessation of RBV. The HEV RNA titer of 6.2 log10 copies/mL on day 77 was unusually high 2.5 months after the onset, suggesting that hepatitis E had already been chronic before immunosuppressive treatment for possible autoimmune hepatitis. After getting married at 23 years old, she had been a housewife and had no comorbidities that might deteriorate her immunity. Chronicity should be kept in mind when encountering HEV infection in elderly and underweight patients.

Keywords: Chronic hepatitis E; Old age; Ribavirin; Underweight.

MeSH terms

  • Adult
  • Aged
  • Antiviral Agents / therapeutic use
  • Azathioprine / therapeutic use
  • Female
  • Hepatitis E virus*
  • Hepatitis E* / drug therapy
  • Hepatitis, Autoimmune* / drug therapy
  • Humans
  • Prednisolone / therapeutic use
  • RNA, Viral
  • Ribavirin / therapeutic use
  • Sustained Virologic Response
  • Young Adult

Substances

  • Ribavirin
  • Antiviral Agents
  • Azathioprine
  • RNA, Viral
  • Prednisolone